Prolonged Responses with BevacizumaB-Cyclophosphamide in Patients with Ovarian Cancer: Clinical Experience with 11 Patients


Introduction: Ovarian cancer continues to be one of the most lethal gynaecological cancers. Bevacizumab is effective either as monotherapy or administered in combination with chemotherapy. Material and methods: This is a retrospective study in patients treated at our institution with bevacizumab-cyclophosphamide, to investigate the efficacy and adverse… (More)